Page last updated: 2024-08-23

fomesafen and Multiple Sclerosis, Chronic Progressive

fomesafen has been researched along with Multiple Sclerosis, Chronic Progressive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aragona, M; Bettolo, CM; Conte, A; Frasca, V; Gabriele, M; Giacomelli, E; Gilio, F; Iacovelli, E; Inghilleri, M; Onesti, E; Pantano, P; Pozzilli, C; Tomassini, V1
Cakmur, R; Genc, A; Idiman, E; Idiman, F; Tataroglu, C1

Trials

2 trial(s) available for fomesafen and Multiple Sclerosis, Chronic Progressive

ArticleYear
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.
    European journal of pain (London, England), 2009, Volume: 13, Issue:5

    Topics: Administration, Oral; Adult; Afferent Pathways; Analgesics; Cannabinoids; Central Nervous System; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neural Conduction; Nociceptors; Pain; Pain Measurement; Pain Threshold; Placebos; Reaction Time; Reflex; Treatment Outcome

2009
Cortical relay time for long latency reflexes in patients with definite multiple sclerosis.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2004, Volume: 31, Issue:2

    Topics: Adolescent; Adult; Cerebral Cortex; Disability Evaluation; Evoked Potentials, Motor; Evoked Potentials, Somatosensory; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Reaction Time; Reflex; Severity of Illness Index; Time Factors

2004